{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T06:04:02Z","timestamp":1768975442834,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,1,31]],"date-time":"2013-01-31T00:00:00Z","timestamp":1359590400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1007\/s00125-013-2836-x","type":"journal-article","created":{"date-parts":[[2013,1,30]],"date-time":"2013-01-30T06:45:26Z","timestamp":1359528326000},"page":"1183-1191","source":"Crossref","is-referenced-by-count":37,"title":["Systemic inhibition of nitric oxide synthesis in non-diabetic individuals produces a significant deterioration in glucose tolerance by increasing insulin clearance and inhibiting insulin secretion"],"prefix":"10.1007","volume":"56","author":[{"given":"A.","family":"Natali","sequence":"first","affiliation":[]},{"given":"R.","family":"Ribeiro","sequence":"additional","affiliation":[]},{"given":"S.","family":"Baldi","sequence":"additional","affiliation":[]},{"given":"A.","family":"Tulipani","sequence":"additional","affiliation":[]},{"given":"M.","family":"Rossi","sequence":"additional","affiliation":[]},{"given":"E.","family":"Venturi","sequence":"additional","affiliation":[]},{"given":"A.","family":"Mari","sequence":"additional","affiliation":[]},{"given":"M. P.","family":"Macedo","sequence":"additional","affiliation":[]},{"given":"E.","family":"Ferrannini","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2013,1,31]]},"reference":[{"key":"2836_CR1","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s00125-009-1313-z","volume":"52","author":"EJ Barrett","year":"2009","unstructured":"Barrett EJ, Eggleston EM, Inyard AC et al (2009) The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action. Diabetologia 52:752\u2013764","journal-title":"Diabetologia"},{"key":"2836_CR2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.tem.2009.03.005","volume":"20","author":"PL Huang","year":"2009","unstructured":"Huang PL (2009) eNOS, metabolic syndrome and cardiovascular disease. Trends Endocrinol Metab 20:295\u2013302","journal-title":"Trends Endocrinol Metab"},{"key":"2836_CR3","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.2337\/diabetes.53.6.1467","volume":"53","author":"AD Lajoix","year":"2004","unstructured":"Lajoix AD, Pugniere M, Roquet F et al (2004) Changes in the dimeric state of neuronal nitric oxide synthase affect the kinetics of secretagogue-induced insulin response. Diabetes 53:1467\u20131474","journal-title":"Diabetes"},{"key":"2836_CR4","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1055\/s-0031-1298015","volume":"120","author":"A Natali","year":"2012","unstructured":"Natali A, Santini E, Delbarba A et al (2012) Effects of short and prolonged mild intracellular nitric oxide manipulations on various aspects of insulin secretion in INS-1E beta-cells. Exp Clin Endocrinol Diabetes 120:210\u2013216","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2836_CR5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0303-7207(01)00610-4","volume":"183","author":"P Beffy","year":"2001","unstructured":"Beffy P, Lajoix AD, Masiello P et al (2001) A constitutive nitric oxide synthase modulates insulin secretion in the INS-1 cell line. Mol Cell Endocrinol 183:41\u201348","journal-title":"Mol Cell Endocrinol"},{"key":"2836_CR6","doi-asserted-by":"crossref","first-page":"E252","DOI":"10.1152\/ajpendo.00186.2011","volume":"301","author":"EJ Barrett","year":"2011","unstructured":"Barrett EJ, Wang H, Upchurch CT, Liu Z (2011) Insulin regulates its own delivery to skeletal muscle by feed-forward actions on the vasculature. Am J Physiol Endocrinol Metab 301:E252\u2013E263","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2836_CR7","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1007\/s00125-010-1716-x","volume":"53","author":"AS Deshmukh","year":"2010","unstructured":"Deshmukh AS, Long YC, de Castro BT et al (2010) Nitric oxide increases cyclic GMP levels, AMP-activated protein kinase (AMPK) alpha1-specific activity and glucose transport in human skeletal muscle. Diabetologia 53:1142\u20131150","journal-title":"Diabetologia"},{"key":"2836_CR8","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1002\/hep.510230637","volume":"23","author":"M Borgs","year":"1996","unstructured":"Borgs M, Bollen M, Keppens S, Yap SH, Stalmans W, Vanstapel F (1996) Modulation of basal hepatic glycogenolysis by nitric oxide. Hepatology 23:1564\u20131571","journal-title":"Hepatology"},{"key":"2836_CR9","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.2337\/db10-0138","volume":"59","author":"Z An","year":"2010","unstructured":"An Z, Winnick JJ, Farmer B et al (2010) A soluble guanylate cyclase-dependent mechanism is involved in the regulation of net hepatic glucose uptake by nitric oxide in vivo. Diabetes 59:2999\u20133007","journal-title":"Diabetes"},{"key":"2836_CR10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/meta.2002.28958","volume":"51","author":"F Sprangers","year":"2002","unstructured":"Sprangers F, Jellema WT, Lopuhaa CE et al (2002) Partial inhibition of nitric oxide synthesis in vivo does not inhibit glucose production in man. Metab Clin Exp 51:57\u201364","journal-title":"Metab Clin Exp"},{"key":"2836_CR11","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.2337\/diabetes.54.5.1340","volume":"54","author":"M Fujimoto","year":"2005","unstructured":"Fujimoto M, Shimizu N, Kunii K, Martyn JA, Ueki K, Kaneki M (2005) A role for iNOS in fasting hyperglycemia and impaired insulin signaling in the liver of obese diabetic mice. Diabetes 54:1340\u20131348","journal-title":"Diabetes"},{"key":"2836_CR12","doi-asserted-by":"crossref","first-page":"e18138","DOI":"10.1371\/journal.pone.0018138","volume":"6","author":"CM Cordes","year":"2011","unstructured":"Cordes CM, Bennett RG, Siford GL, Hamel FG (2011) Redox regulation of insulin degradation by insulin-degrading enzyme. PLoS One 6:e18138","journal-title":"PLoS One"},{"key":"2836_CR13","doi-asserted-by":"crossref","first-page":"684","DOI":"10.2337\/diabetes.49.5.684","volume":"49","author":"RR Shankar","year":"2000","unstructured":"Shankar RR, Wu Y, Shen HQ, Zhu JS, Baron AD (2000) Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance. Diabetes 49:684\u2013687","journal-title":"Diabetes"},{"key":"2836_CR14","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2337\/diabetes.41.3.368","volume":"41","author":"E Cauter Van","year":"1992","unstructured":"Van Cauter E, Mestrez F, Sturis J, Polonsky KS (1992) Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368\u2013377","journal-title":"Diabetes"},{"key":"2836_CR15","doi-asserted-by":"crossref","first-page":"E1159","DOI":"10.1152\/ajpendo.00093.2002","volume":"283","author":"A Mari","year":"2002","unstructured":"Mari A, Schmitz O, Gastaldelli A, Oestergaard T, Nyholm B, Ferrannini E (2002) Meal and oral glucose tests for the assessment of \u00df-cell function: modeling analysis in normal subjects. Am J Physiol Endocrinol Metab 283:E1159\u2013E1166","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"Suppl 1","key":"2836_CR16","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.2337\/diabetes.51.2007.S221","volume":"51","author":"A Mari","year":"2002","unstructured":"Mari A, Tura A, Gastaldelli A, Ferrannini E (2002) Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation. Diabetes 51(Suppl 1):S221\u2013S226","journal-title":"Diabetes"},{"key":"2836_CR17","doi-asserted-by":"crossref","first-page":"G29","DOI":"10.1152\/ajpgi.2001.281.1.G29","volume":"281","author":"WW Lautt","year":"2001","unstructured":"Lautt WW, Macedo MP, Sadri P, Takayama S, Duarte Ramos F, Legare DJ (2001) Hepatic parasympathetic (HISS) control of insulin sensitivity determined by feeding and fasting. Am J Physiol Gastrointest Liver Physiol 281:G29\u2013G36","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2836_CR18","doi-asserted-by":"crossref","first-page":"G1227","DOI":"10.1152\/ajpgi.00511.2004","volume":"288","author":"D Gentilcore","year":"2005","unstructured":"Gentilcore D, Visvanathan R, Russo A et al (2005) Role of nitric oxide mechanisms in gastric emptying of, and the blood pressure and glycemic responses to, oral glucose in healthy older subjects. Am J Physiol Gastrointest Liver Physiol 288:G1227\u2013G1232","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2836_CR19","doi-asserted-by":"crossref","first-page":"E768","DOI":"10.1152\/ajpendo.00184.2007","volume":"294","author":"MC Moore","year":"2008","unstructured":"Moore MC, Dicostanzo CA, Smith MS et al (2008) Hepatic portal venous delivery of a nitric oxide synthase inhibitor enhances net hepatic glucose uptake. Am J Physiol Endocrinol Metab 294:E768\u2013E777","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2836_CR20","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s00210-003-0774-8","volume":"368","author":"X Li","year":"2003","unstructured":"Li X, Benjamin IS, Alexander B (2003) The role of nitric oxide in systemic and hepatic haemodynamics in the rat in vivo. N Schmied Arch Pharmacol 368:142\u2013149","journal-title":"N Schmied Arch Pharmacol"},{"key":"2836_CR21","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s00125-011-2343-x","volume":"55","author":"S Majumdar","year":"2012","unstructured":"Majumdar S, Genders AJ, Inyard AC, Frison V, Barrett EJ (2012) Insulin entry into muscle involves a saturable process in the vascular endothelium. Diabetologia 55:450\u2013456","journal-title":"Diabetologia"},{"key":"2836_CR22","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1161\/01.HYP.31.1.104","volume":"31","author":"CJ O\u2019Callaghan","year":"1998","unstructured":"O\u2019Callaghan CJ, Komersova K, Louis WJ (1998) Acute effects of blood pressure elevation on insulin clearance in normotensive healthy subjects. Hypertension 31:104\u2013109","journal-title":"Hypertension"},{"key":"2836_CR23","doi-asserted-by":"crossref","first-page":"H190","DOI":"10.1152\/ajpheart.00366.2007","volume":"294","author":"JM Wecht","year":"2008","unstructured":"Wecht JM, Weir JP, Goldstein DS et al (2008) Direct and reflexive effects of nitric oxide synthase inhibition on blood pressure. Am J Physiol Heart Circ Physiol 294:H190\u2013H197","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2836_CR24","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1006\/niox.1999.0235","volume":"3","author":"TW Balon","year":"1999","unstructured":"Balon TW, Jasman AP, Young JC (1999) Effects of chronic N(omega)-nitro-L-arginine methyl ester administration on glucose tolerance and skeletal muscle glucose transport in the rat. Nitric Oxide 3:312\u2013320","journal-title":"Nitric Oxide"},{"key":"2836_CR25","doi-asserted-by":"crossref","first-page":"e20818","DOI":"10.1371\/journal.pone.0020818","volume":"6","author":"SO Abdul-Hay","year":"2011","unstructured":"Abdul-Hay SO, Kang D, McBride M, Li L, Zhao J, Leissring MA (2011) Deletion of insulin-degrading enzyme elicits antipodal, age-dependent effects on glucose and insulin tolerance. PLoS One 6:e20818","journal-title":"PLoS One"},{"key":"2836_CR26","doi-asserted-by":"crossref","first-page":"E402","DOI":"10.1152\/ajpendo.00013.2011","volume":"301","author":"MO Goodarzi","year":"2011","unstructured":"Goodarzi MO, Cui J, Chen YD, Hsueh WA, Guo X, Rotter JI (2011) Fasting insulin reflects heterogeneous physiological processes: role of insulin clearance. Am J Physiol Endocrinol Metab 301:E402\u2013E408","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2836_CR27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1161\/01.HYP.29.1.111","volume":"29","author":"D Lender","year":"1997","unstructured":"Lender D, Arauz-Pacheco C, Adams-Huet B, Raskin P (1997) Essential hypertension is associated with decreased insulin clearance and insulin resistance. Hypertension 29:111\u2013114","journal-title":"Hypertension"},{"key":"2836_CR28","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.2337\/diabetes.50.5.1030","volume":"50","author":"B Ahren","year":"2001","unstructured":"Ahren B, Holst JJ (2001) The cephalic insulin response to meal ingestion in humans is dependent on both cholinergic and noncholinergic mechanisms and is important for postprandial glycemia. Diabetes 50:1030\u20131038","journal-title":"Diabetes"},{"key":"2836_CR29","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1210\/jc.86.3.1253","volume":"86","author":"DA D\u2019Alessio","year":"2001","unstructured":"D\u2019Alessio DA, Kieffer TJ, Taborsky GJ Jr, Havel PJ (2001) Activation of the parasympathetic nervous system is necessary for normal meal-induced insulin secretion in rhesus macaques. J Clin Endocrinol Metab 86:1253\u20131259","journal-title":"J Clin Endocrinol Metab"},{"key":"2836_CR30","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1172\/JCI117621","volume":"94","author":"U Scherrer","year":"1994","unstructured":"Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P (1994) Nitric oxide release accounts for insulin\u2019s vascular effects in humans. J Clin Invest 94:2511\u20132515","journal-title":"J Clin Invest"},{"key":"2836_CR31","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1172\/JCI118124","volume":"96","author":"AD Baron","year":"1995","unstructured":"Baron AD, Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G (1995) Insulin-mediated skeletal muscle vasodilatation contributes to both insulin sensitivity and responsiveness in lean humans. J Clin Invest 96:786\u2013792","journal-title":"J Clin Invest"},{"key":"2836_CR32","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1161\/01.HYP.31.2.632","volume":"31","author":"A Natali","year":"1998","unstructured":"Natali A, Galvan AQ, Pecori N, Sanna G, Toschi E, Ferrannini E (1998) Vasodilation with sodium nitroprusside does not improve insulin action in essential hypertension. Hypertension 31:632\u2013636","journal-title":"Hypertension"},{"key":"2836_CR33","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1161\/01.ATV.20.11.2401","volume":"20","author":"A Natali","year":"2000","unstructured":"Natali A, Sironi AM, Toschi E et al (2000) Effect of vitamin C on forearm blood flow and glucose metabolism in essential hypertension. Arterioscler Thromb Vasc Biol 20:2401\u20132406","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-013-2836-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-013-2836-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-013-2836-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T01:10:48Z","timestamp":1562634648000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-013-2836-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,31]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["2836"],"URL":"https:\/\/doi.org\/10.1007\/s00125-013-2836-x","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,31]]}}}